✦ LIBER ✦

Abnormalities of primary hemostasis in patients with liver cirrhosis

✍ Scribed by R. Leo; C. Alessandri; E. Vezza; S. Basili; C. Camastra; M. Alessandroni; F. Violi

Book ID: 118371417
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 85 KB
Volume: 70
Category: Article
ISSN: 0049-3848
DOI: 10.1016/0049-3848(93)90330-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hemostasis activation in patients with l

Hemostasis activation in patients with liver cirrhosis

✍ Th. Vukovich; H. Teufelsbauer; M. Fritzer; S. Kreuzer; P. Knoflach 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 507 KB

Lipoprotein abnormalities in patients wi

Lipoprotein abnormalities in patients with early primary biliary cirrhosis

✍ A. ALY; K. CARLSON; C. JOHANSSON; P. KIRSTEIN; S. RÖSSNER; L. WALLENTIN 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 721 KB

Lung Function Abnormalities in Patients

Lung Function Abnormalities in Patients with Primary Biliary Cirrhosis

✍ UDDENFELDT, PER ;BJERLE, PER ;DANIELSSON, ÅKE ;NYSTRÖM, LENNART ;STJERNBERG, NIL 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 456 KB

Abnormalities in erythrocyte membrane ph

Abnormalities in erythrocyte membrane phospholipids in patients with liver cirrhosis

✍ D. Alvaro; M. Angelico; A.F. Attili; A. De Santis; U. Pieche; L. Capocaccia 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 480 KB

Abnormal carbohydrate metabolism in pati

Abnormal carbohydrate metabolism in patients with liver cirrhosis;in vitrostudy

✍ Viera Dzúriková; T. R. Niederland; Eva Brixová; R. Dzúrik; Viera Hupková; J. Hol 📂 Article 📅 1972 🏛 Springer 🌐 English ⚖ 381 KB

Abnormal Glucuronidation of Zomepirac in

Abnormal Glucuronidation of Zomepirac in Patients with Cirrhosis of the Liver

✍ Felix Witassek; Johannes Bircher; Philipp Huguenin; Rudolf Preisig 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 762 KB

The disposition of zomepirac was investigated in 18 patients with various liver diseases and in 10 healthy normal subjects in order to further test the hypothesis that glucuronidation of drugs may be spared in liver disease. Severity of the liver disease was assessed by the galactose elimination cap